Omeros OMER
NASDAQ OMER
$18.61 +0.14 (+0.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Omeros (OMER) Return on Equity [ROE] (2011 - 2023)

Updated

Omeros' Return on Equity [ROE] came in at -388.17% for FY2023, down 474.81 percentage points from 86.63% in FY2022.

Analysis

Omeros (OMER) Return on Equity [ROE] (2011 - 2023) Analysis & Trends

Going back to FY2010, Omeros' Return on Equity [ROE] data covers 4 years.

  • The FY2023 figure represents the lowest annual Return on Equity [ROE] since FY2011.
  • Per Business Quant, earlier years put Return on Equity [ROE] at 86.63% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Omeros 1.34 Bn 1.34 Bn 27.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 609.58%
Jun 30, 2023 106.78%
Mar 31, 2023 66.46%
Dec 31, 2022 240.88%
Mar 31, 2022 2,082.35%
Dec 31, 2017 -1,717.21%
Jun 30, 2015 -503.45%
Sep 30, 2011 -393.40%
API Access

Omeros Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OMER&period=max&api_key=YOUR_API_KEY